Novavax Inc - Company Profile

Powered by

All the sales intelligence you need on Novavax Inc in one solution.

$395 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Novavax Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Novavax Inc.

Back to companies

Novavax Inc: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

View up-to-date information on Novavax Inc patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
AU2022270082A1 Application Coronavirus and influenza compositions and methods for using them C12N2760/16134; C12N2760/16234; C12N2770/20034; A61K2039/55555; A61K2039/55577; A61K2039/70; A61K39/12; A61K39/145; A61K39/215; A61K9/0019; A61K9/51; A61K9/5169; A61P31/14; A61P31/16 November 16, 2023
AU2023248200A1 Application Vaccine compositions having improved stability and immunogenicity C12N2710/14143; C12N2760/16134; C12N7/00; C12N2760/14134; C12N2760/16234; C12N2760/14171; A61K39/12; A61K39/385; A61K39/39; C12N2760/16122; A61P37/04; A61K2039/55505; A61K47/02; A61K2039/54; A61K2039/55555; C12N2760/18534; C12N2760/16151; C12N2760/16251; C12N2760/18522; A61K39/155; C12N2760/16222; A61P31/16; A61K9/1611; A61K9/1617; A61K2039/55577; A61P31/12; A61K47/183; A61K9/1623; A61K9/0019; A61P31/14 November 09, 2023
WO2023192949A3 Application Compositions and methods for inducing an immune response against epstein-barr virus C12N2710/16222; C12N2710/16234; A61K2039/55577; A61K2039/6031; A61K39/12; C07K14/005 November 09, 2023
IL305911A Application Multivalent influenza nanoparticle vaccines C12N2760/16134; C12N2760/16171; C12N2760/16234; C12N2760/16271; A61K2039/55555; A61K2039/55577; A61K2039/70; A61K39/12; A61K39/145; A61K39/295; A61K9/0051; A61K9/51; A61P31/16 November 01, 2023
IL306088A Application Coronavirus vaccine formulations C12N2770/20022; C12N2770/20034; C12N2770/20071; A61K2039/545; A61K2039/55577; A61K2039/57; A61K2039/575; A61K39/12; A61K39/215; A61K39/39; A61P31/14; C07K14/005 November 01, 2023
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Learn more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer